BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8809278)

  • 1. Limiting vancomycin use to combat vancomycin-resistant Enterococcus faecium.
    Belliveau PP; Rothman AL; Maday CE
    Am J Health Syst Pharm; 1996 Jul; 53(13):1570-5. PubMed ID: 8809278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of pharmacy policies designed to limit inappropriate vancomycin use: a population-based assessment.
    Thomas AR; Cieslak PR; Strausbaugh LJ; Fleming DW
    Infect Control Hosp Epidemiol; 2002 Nov; 23(11):683-8. PubMed ID: 12452297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium.
    Anglim AM; Klym B; Byers KE; Scheld WM; Farr BM
    Arch Intern Med; 1997 May; 157(10):1132-6. PubMed ID: 9164379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A vancomycin monitoring program at a community hospital.
    Goeckner BJ; Hendershot E; Scott K; Drake M
    Jt Comm J Qual Improv; 1998 Jul; 24(7):379-85. PubMed ID: 9689571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vancomycin resistant enterococci in Austria].
    Allerberger F; Lass-Flörl C; Dierich MP; Hirschl AM; Presterl E; Haas G; Klare I; Witte W
    Wien Klin Wochenschr; 1997 May; 109(9):312-20. PubMed ID: 9265389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a vancomycin restriction policy on use and cost of vancomycin and incidence of vancomycin-resistant Enterococcus.
    Morgan AS; Brennan PJ; Fishman NO
    Ann Pharmacother; 1997 Sep; 31(9):970-3. PubMed ID: 9296233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare-associated vancomycin resistant Enterococcus faecium infections in the Mansoura University Hospitals intensive care units, Egypt.
    Moemen D; Tawfeek D; Badawy W
    Braz J Microbiol; 2015; 46(3):777-83. PubMed ID: 26413060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin use in a university medical center: effect of a vancomycin continuation form.
    Evans ME; Millheim ET; Rapp RP
    Infect Control Hosp Epidemiol; 1999 Jun; 20(6):417-20. PubMed ID: 10395144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enforcing a policy for restricting antimicrobial drug use.
    Maswoswe JJ; Okpara AU
    Am J Health Syst Pharm; 1995 Jul; 52(13):1433-5. PubMed ID: 7671042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vancomycin-resistant enterococci . Work Group Hospital Infection Epidemiology].
    Endtz HP; van Belkum A; van Duin J
    Ned Tijdschr Geneeskd; 1997 Jan; 141(2):108-9. PubMed ID: 9036340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin-resistant Enterococcus faecium shunt infection in an infant: an antibiotic cure.
    Nachman SA; Verma R; Egnor M
    Microb Drug Resist; 1995; 1(1):95-6. PubMed ID: 9156389
    [No Abstract]   [Full Text] [Related]  

  • 12. Stopping the spread of vancomycin-resistant enterococci.
    Krumins I; Gibbons N
    MLO Med Lab Obs; 1999 Mar; 31(3):30-2, 34; quiz 36-7. PubMed ID: 10538566
    [No Abstract]   [Full Text] [Related]  

  • 13. Vancomycin use in a university medical center: comparison with hospital infection control practices advisory committee guidelines.
    Evans ME; Kortas KJ
    Infect Control Hosp Epidemiol; 1996 Jun; 17(6):356-9. PubMed ID: 8805065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin use in a large teaching hospital in Shiraz, Islamic Republic of Iran, 2003.
    Askarian M; Assadian O; Safaee G; Golkar A; Namazi S; Movahed MR
    East Mediterr Health J; 2007; 13(5):1195-201. PubMed ID: 18290414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin-resistant enterococci in a Singapore teaching hospital prior to 2005.
    Fisher DA; Lin R; Chai L; Kumarasinghe G; Singh K; Tambyah PA
    Singapore Med J; 2005 Jun; 46(6):311-2. PubMed ID: 15902362
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience.
    Fournier S; Brossier F; Fortineau N; Gillaizeau F; Akpabie A; Aubry A; Barbut F; Chedhomme FX; Kassis-Chikhani N; Lucet JC; Robert J; Seytre D; Simon I; Vanjak D; Zahar JR; Brun-Buisson C; Jarlier V
    Euro Surveill; 2012 Jul; 17(30):. PubMed ID: 22856512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Order form for restricting vancomycin prescribing.
    Burke CE; Piper J; Holloway W
    Am J Health Syst Pharm; 1997 Aug; 54(16):1893, 1897. PubMed ID: 9269524
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vancomycin resistant Enterococci (VRE)].
    Lesens O
    Nephrol Ther; 2009 Jun; 5 Suppl 4():S261-4. PubMed ID: 19596346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
    Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin-resistant enterococci.
    Rubinstein E; Keynan Y
    Crit Care Clin; 2013 Oct; 29(4):841-52. PubMed ID: 24094380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.